507 related articles for article (PubMed ID: 31888754)
1. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
2. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus.
Kikuchi S; Santiago-Raber ML; Amano H; Amano E; Fossati-Jimack L; Moll T; Kotzin BL; Izui S
J Immunol; 2006 Mar; 176(5):3240-7. PubMed ID: 16493085
[TBL] [Abstract][Full Text] [Related]
3. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
4. Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus.
Kofler R; Schreiber RD; Dixon FJ; Theofilopoulos AN
Cell Immunol; 1984 Aug; 87(1):92-100. PubMed ID: 6204780
[TBL] [Abstract][Full Text] [Related]
5. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
[TBL] [Abstract][Full Text] [Related]
6. FcγRIIb on B Cells and Myeloid Cells Modulates B Cell Activation and Autoantibody Responses via Different but Synergistic Pathways in Lupus-Prone
Lin Q; Ohtsuji M; Amano H; Tsurui H; Tada N; Sato R; Fukuyama H; Nishimura H; Verbeek JS; Hirose S
J Immunol; 2018 Dec; 201(11):3199-3210. PubMed ID: 30373853
[TBL] [Abstract][Full Text] [Related]
7. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
[TBL] [Abstract][Full Text] [Related]
8. The role of the Yaa gene in lupus syndrome.
Izui S; Merino R; Fossati L; Iwamoto M
Int Rev Immunol; 1994; 11(3):211-30. PubMed ID: 7930846
[TBL] [Abstract][Full Text] [Related]
9. Phenotype conversion from rheumatoid arthritis to systemic lupus erythematosus by introduction of Yaa mutation into FcγRIIB-deficient C57BL/6 mice.
Kawano S; Lin Q; Amano H; Kaneko T; Nishikawa K; Tsurui H; Tada N; Nishimura H; Takai T; Shirai T; Takasaki Y; Hirose S
Eur J Immunol; 2013 Mar; 43(3):770-8. PubMed ID: 23280344
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
11. Self-reactive T cells in murine lupus: analysis of genetic contributions and development of self-tolerance.
Kotzin BL; Herron LR; Babcock SK; Portanova JP; Palmer E
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S35-46. PubMed ID: 2571438
[TBL] [Abstract][Full Text] [Related]
12. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice.
Bolland S; Yim YS; Tus K; Wakeland EK; Ravetch JV
J Exp Med; 2002 May; 195(9):1167-74. PubMed ID: 11994421
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
14. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.
Richez C; Yasuda K; Bonegio RG; Watkins AA; Aprahamian T; Busto P; Richards RJ; Liu CL; Cheung R; Utz PJ; Marshak-Rothstein A; Rifkin IR
J Immunol; 2010 Jan; 184(2):796-806. PubMed ID: 20007534
[TBL] [Abstract][Full Text] [Related]
15. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
Yim LY; Lau CS; Chan VS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
[TBL] [Abstract][Full Text] [Related]
16. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
17. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
18. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.
Jiang Y; Hirose S; Sanokawa-Akakura R; Abe M; Mi X; Li N; Miura Y; Shirai J; Zhang D; Hamano Y; Shirai T
Int Immunol; 1999 Oct; 11(10):1685-91. PubMed ID: 10508186
[TBL] [Abstract][Full Text] [Related]
19. A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.
Leng L; Chen L; Fan J; Greven D; Arjona A; Du X; Austin D; Kashgarian M; Yin Z; Huang XR; Lan HY; Lolis E; Nikolic-Paterson D; Bucala R
J Immunol; 2011 Jan; 186(1):527-38. PubMed ID: 21106847
[TBL] [Abstract][Full Text] [Related]
20. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
Pollard KM; Pearson DL; Hultman P; Hildebrandt B; Kono DH
Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):729-35. PubMed ID: 10502538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
